Literature DB >> 26951728

Helsinki Criteria update 2014: asbestos continues to be a challenge for disease prevention and attribution.

Harri Vainio1,2, Panu Oksa3, Timo Tuomi3, Tapio Vehmas3,4, Henrik Wolff3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26951728     DOI： 10.19191/EP16.1S1.P015.025

Source DB:  PubMed          Journal:  Epidemiol Prev        ISSN： 1120-9763            Impact factor:   1.901


× No keyword cloud information.
  5 in total

1.  Relations between vital capacity, CO diffusion capacity and computed tomographic findings of former asbestos-exposed patients: a cross-sectional study.

Authors:  Alexandra Marita Preisser; Katja Schlemmer; Robert Herold; Azien Laqmani; Claudia Terschüren; Volker Harth
Journal:  J Occup Med Toxicol       Date:  2020-07-01       Impact factor: 2.646

2.  Chromatographic Detection of 8-Hydroxy-2'-Deoxyguanosine in Leukocytes of Asbestos Exposed Workers for Assessing Past and Recent Carcinogen Exposures.

Authors:  Filippo Cellai; Stefano Bonassi; Alfonso Cristaudo; Alessandra Bonotti; Monica Neri; Marcello Ceppi; Marco Bruzzone; Mirta Milić; Armelle Munnia; Marco Peluso
Journal:  Diagnostics (Basel)       Date:  2020-04-21

3.  Mesothelioma and Colorectal Cancer: Report of Four Cases with Synchronous and Metachronous Presentation.

Authors:  Gabriella Serio; Federica Pezzuto; Francesco Fortarezza; Andrea Marzullo; Maria Celeste Delfino; Antonio d'Amati; Daniele Egidio Romano; Sonia Maniglio; Concetta Caporusso; Teresa Lettini; Domenica Cavone; Luigi Vimercati
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

4.  Restrictions of VC and DLCO in relation to asbestos-related computed tomographic findings quantified by ICOERD-based parameters.

Authors:  Lennart Ströker; Kersten Peldschus; Robert Herold; Volker Harth; Alexandra Marita Preisser
Journal:  BMC Pulm Med       Date:  2022-06-20       Impact factor: 3.320

5.  Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients.

Authors:  Takumi Kishimoto; Nobukazu Fujimoto; Takeshi Ebara; Toyonori Omori; Tetsuya Oguri; Akio Niimi; Takako Yokoyama; Munehiro Kato; Ikuji Usami; Masayuki Nishio; Kosho Yoshikawa; Takeshi Tokuyama; Mouka Tamura; Yoshifumi Yokoyama; Ken Tsuboi; Yoichi Matsuo; Jiegou Xu; Satoru Takahashi; Mohamed Abdelgied; William T Alexander; David B Alexander; Hiroyuki Tsuda
Journal:  BMC Cancer       Date:  2019-12-10       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.